- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Mitochondrial Disorders
Authors
Keywords
-
Journal
JOURNAL OF CHILD NEUROLOGY
Volume 29, Issue 9, Pages 1235-1240
Publisher
SAGE Publications
Online
2014-07-02
DOI
10.1177/0883073814538509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy
- (2013) T. Klopstock et al. BRAIN
- First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
- (2013) Hazel H Szeto BRITISH JOURNAL OF PHARMACOLOGY
- Targeting mitochondrial cardiolipin and the cytochromec/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
- (2013) A V Birk et al. BRITISH JOURNAL OF PHARMACOLOGY
- l-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders
- (2013) Graziela S. Ribas et al. GENE
- Reduction of Early Reperfusion Injury With the Mitochondria-Targeting Peptide Bendavia
- (2013) David A. Brown et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension
- (2013) Alfonso Eirin et al. JOURNAL OF HYPERTENSION
- Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management
- (2013) Sumit Parikh et al. MITOCHONDRION
- Coenzyme Q10 deficiency in mitochondrial DNA depletion syndromes
- (2013) Raquel Montero et al. MITOCHONDRION
- Practice patterns of mitochondrial disease physicians in North America. Part 1: Diagnostic and clinical challenges
- (2013) Sumit Parikh et al. MITOCHONDRION
- Glutathione: A redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies
- (2013) Anna Pastore et al. MOLECULAR GENETICS AND METABOLISM
- Review of Clinical Trials for Mitochondrial Disorders: 1997–2012
- (2013) Douglas S. Kerr Neurotherapeutics
- Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease
- (2013) Charalampos Mermigkis et al. Sleep and Breathing
- Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2
- (2012) Samantha E. Marin et al. GENE
- Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ10)
- (2012) Rita Horvath JOURNAL OF INHERITED METABOLIC DISEASE
- EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome
- (2012) Diego Martinelli et al. MOLECULAR GENETICS AND METABOLISM
- Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease
- (2012) Francis G. Blankenberg et al. MOLECULAR GENETICS AND METABOLISM
- Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria‐Targeting Cytoprotective Peptide
- (2012) Robert A. Kloner et al. Journal of the American Heart Association
- Cocoa and Chocolate in Human Health and Disease
- (2011) David L. Katz et al. ANTIOXIDANTS & REDOX SIGNALING
- α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
- (2011) William D. Shrader et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Idebenone Treatment In Leber's Hereditary Optic Neuropathy
- (2011) V. Carelli et al. BRAIN
- A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy
- (2011) Thomas Klopstock et al. BRAIN
- (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle
- (2011) Leonardo Nogueira et al. JOURNAL OF PHYSIOLOGY-LONDON
- Why are there no proven therapies for genetic mitochondrial diseases?
- (2011) Peter W. Stacpoole MITOCHONDRION
- Initial experience in the treatment of inherited mitochondrial disease with EPI-743
- (2011) Gregory M. Enns et al. MOLECULAR GENETICS AND METABOLISM
- Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria
- (2010) Dao-Fu Dai et al. AGING CELL
- A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
- (2010) David R. Lynch et al. ARCHIVES OF NEUROLOGY
- Coenzyme Q and mitochondrial disease
- (2010) Catarina M. Quinzii et al. Developmental Disabilities Research Reviews
- Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
- (2010) Saskia Koene et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A randomized trial of coenzyme Q10in mitochondrial disorders
- (2010) Elisa I. Glover et al. MUSCLE & NERVE
- A Nonsense Mutation in COQ9 Causes Autosomal-Recessive Neonatal-Onset Primary Coenzyme Q10 Deficiency: A Potentially Treatable Form of Mitochondrial Disease
- (2009) Andrew J. Duncan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A modern approach to the treatment of mitochondrial disease
- (2009) Sumit Parikh et al. Current Treatment Options in Neurology
- ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
- (2009) Wen-Chen Liang et al. NEUROMUSCULAR DISORDERS
- Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia
- (2009) K. R. Atkuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies☆
- (2008) M.A. Tarnopolsky ADVANCED DRUG DELIVERY REVIEWS
- Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial
- (2008) Maria Stamelou et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More